Health X Platform Limited (NSE:HEALTHX)
India · Delayed Price · Currency is INR 300.85
-1.55 (-0.51%)
Aug 21, 2026, 3:29 PM IST
Health X Platform Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 9,570 | 8,174 | 7,712 | 9,664 | 7,016 | 11,391 | |
Market Cap Growth | 10.12% | 5.99% | -20.20% | 37.75% | -38.41% | 206.99% |
Enterprise Value | 10,768 | 9,933 | 9,506 | 11,993 | 6,727 | 11,741 |
Last Close Price | 300.85 | 256.95 | 242.42 | 303.80 | 220.55 | 358.10 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 695.10 | - | 108.80 | - | 1.82 |
PS Ratio | 0.63 | 0.59 | 0.67 | 0.68 | 0.66 | 1.78 |
PB Ratio | 1.25 | 1.07 | 0.89 | 0.97 | 0.71 | 1.04 |
P/TBV Ratio | 1.58 | 1.35 | 1.22 | 1.33 | 0.98 | 1.44 |
P/FCF Ratio | - | - | - | 44.67 | - | - |
P/OCF Ratio | - | - | - | 26.95 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.71 | 0.72 | 0.83 | 0.84 | 0.63 | 1.84 |
EV/EBITDA Ratio | - | 161.40 | - | 19.80 | - | - |
EV/EBIT Ratio | - | - | - | 22.42 | - | - |
EV/FCF Ratio | - | - | - | 55.44 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.00 | 0.00 | 0.01 | 0.00 |
Debt / EBITDA Ratio | - | 4.17 | - | 0.06 | - | - |
Debt / FCF Ratio | - | - | - | 0.18 | - | - |
Net Debt / Equity Ratio | -0.01 | -0.01 | -0.64 | -0.47 | -0.41 | -0.48 |
Net Debt / EBITDA Ratio | 0.22 | -0.74 | 68.90 | -7.77 | 18.40 | 12.86 |
Net Debt / FCF Ratio | - | 0.05 | 19.87 | -21.77 | 3.14 | 2.50 |
Asset Turnover | - | 1.44 | 1.08 | 1.22 | 0.85 | 0.81 |
Inventory Turnover | - | 10.14 | 9.49 | 8.66 | 6.85 | 6.59 |
Quick Ratio | - | 0.42 | 7.75 | 9.77 | 5.18 | 8.66 |
Current Ratio | - | 2.22 | 9.69 | 12.55 | 7.56 | 10.74 |
Return on Equity (ROE) | - | -0.18% | -14.33% | 0.59% | -9.53% | 130.72% |
Return on Assets (ROA) | - | -0.03% | -0.79% | 2.84% | -1.45% | -3.55% |
Return on Invested Capital (ROIC) | -3.70% | -0.08% | -3.17% | 9.64% | -5.02% | -9.27% |
Return on Capital Employed (ROCE) | - | -0.10% | -1.50% | 4.90% | -2.60% | -3.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -2.11% | 0.14% | -11.82% | 0.92% | -10.29% | 55.02% |
FCF Yield | -9.27% | -10.86% | -3.59% | 2.24% | -18.74% | -18.60% |
Buyback Yield / Dilution | 0.11% | 0.09% | - | - | - | - |